Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by EIIJ SHINOZAKI
Angiotensin II Type-1 Receptor Blockers Enhance the Effects of Bevacizumab-Based Chemotherapy in Metastatic Colorectal Cancer Patients
Molecular and Clinical Oncology
Cancer Research
Oncology
Related publications
Organoprotecive Effects of Angiotensin II Receptor Blockers in Patients With Type 2 Diabetes Mellitus
Diabetes Mellitus
Internal Medicine
Endocrinology
Metabolism
Diabetes
Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
Polymorphisms of the Angiotensin II Type 1 Receptor Gene Affect Antihypertensive Response to Angiotensin Receptor Blockers in Hypertensive Chinese
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
Effect and Safety of Bevacizumab-Containing Chemotherapy Treatment in Chinese Patients With Metastatic Colorectal Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Perioperative Chemotherapy With or Without Bevacizumab in Patients With Metastatic Colorectal Cancer Undergoing Liver Resection
Clinical Colorectal Cancer
Oncology
Gastroenterology
Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical Applications
Neurotoxicity Research
Neuroscience
Toxicology
Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer
JAMA Oncology
Cancer Research
Oncology
Bevacizumab May Overcome Clinical Tumor Drug Resistance to Irinotecan Based Chemotherapy in Patients With Metastatic Colorectal Cancer: Case Report
The Open Colorectal Cancer Journal